A Systematic Review of the Prevalence of Schizophrenia by Saha, Sukanta et al.
A Systematic Review
of the Prevalence of Schizophrenia
Sukanta Saha
1, David Chant
1,2, Joy Welham
1, John McGrath
1,2*
1 Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Wacol, Australia, 2 Department of Psychiatry, University of Queensland, St. Lucia,
Australia
Competing Interests: The authors
have declared that no competing
interests exist.
Author Contributions: JM designed
the study. SS, DC, JW, and JM
analyzed the data and contributed
to writing the paper.
Academic Editor: Steven E.
Hyman, Harvard University,
United States of America
Citation: Saha S, Chant D, Welham
J, McGrath J (2005) A systematic
review of the prevalence of schiz-
ophrenia. PLoS Med 2(5): e141.
Received: February 15, 2005
Accepted: March 29, 2005
Published: May 31, 2005
DOI:
10.1371/journal.pmed.0020141
Copyright:  2005 Saha et al. This
is an open-access article distrib-
uted under the terms of the Crea-
tive Commons Attribution License,
which permits unrestricted use,
distribution, and reproduction in
any medium, provided the original
work is properly cited.
Abbreviations: LMR, lifetime mor-
bid risk; NOS, not otherwise
speciﬁed
*To whom correspondence should
be addressed. E-mail:
john_mcgrath@qcsr.uq.edu.au
ABSTRACT
Background
Understanding the prevalence of schizophrenia has important implications for both health
service planning and risk factor epidemiology. The aims of this review are to systematically
identify and collate studies describing the prevalence of schizophrenia, to summarize the
findings of these studies, and to explore selected factors that may influence prevalence
estimates.
Methods and Findings
Studies with original data related to the prevalence of schizophrenia (published 1965–2002)
were identified via searching electronic databases, reviewing citations, and writing to authors.
These studies were divided into ‘‘core’’ studies, ‘‘migrant’’ studies, and studies based on ‘‘other
special groups.’’ Between- and within-study filters were applied in order to identify discrete
prevalence estimates. Cumulative plots of prevalence estimates were made and the
distributions described when the underlying estimates were sorted according to prevalence
type (point, period, lifetime, and lifetime morbid risk). Based on combined prevalence
estimates, the influence of selected key variables was examined (sex, urbanicity, migrant status,
country economic index, and study quality).
A total of 1,721 prevalence estimates from 188 studies were identified. These estimates were
drawn from 46 countries, and were based on an estimated 154,140 potentially overlapping
prevalent cases. We identified 132 core studies, 15 migrant studies, and 41 studies based on
other special groups. The median values per 1,000 persons (10%–90% quantiles) for the
distributions for point, period, lifetime, and lifetime morbid risk were 4.6 (1.9–10.0), 3.3 (1.3–
8.2), 4.0 (1.6–12.1), and 7.2 (3.1–27.1), respectively. Based on combined prevalence estimates,
we found no significant difference (a) between males and females, or (b) between urban, rural,
and mixed sites. The prevalence of schizophrenia in migrants was higher compared to native-
born individuals: the migrant-to-native-born ratio median (10%–90% quantile) was 1.8 (0.9–6.4).
When sites were grouped by economic status, prevalence estimates from ‘‘least developed’’
countries were significantly lower than those from both ‘‘emerging’’ and ‘‘developed’’ sites (p
= 0.04). Studies that scored higher on a quality score had significantly higher prevalence
estimates (p=0.02).
Conclusions
There is a wealth of data about the prevalence of schizophrenia. These gradients, and the
variability found in prevalence estimate distributions, can provide direction for future
hypothesis-driven research.
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Schizophrenia is a disabling group of brain disorders
characterized by symptoms such as hallucinations, delusions,
disorganized communication, poor planning, reduced moti-
vation, and blunted affect. While the incidence of the
disorder is relatively low (median value 15.2 per 100,000
persons per year) [1], the condition is one of the major
contributors to the global burden of disease [2]. The
substantial burden of disease is a reﬂection of two features
of schizophrenia: (a) the disorder usually has its onset in early
adulthood, and (b) despite optimal treatment, approximately
two-thirds of affected individuals have persisting or ﬂuctuat-
ing symptoms [3].
Understanding the ‘‘epidemiological landscape’’ of schizo-
phrenia requires many different types of descriptive studies
[4]. Studies that estimate the incidence of schizophrenia are
required in order to identify gradients across time and/or
place. These gradients allow us to generate candidate risk
factors that may underlie variations in the disorder. However,
studies that report the prevalence of a disorder are also
important. Estimating the proportion of a population
affected with schizophrenia is central to health service
planning. With respect to estimating the burden of disorder,
prevalence proportions can provide insights into how
incidence rates are refracted via different trajectories (e.g.,
recovery, chronicity, or early death). The statement ‘‘preva-
lence = incidence þ course of illness’’ oversimpliﬁes the
dynamic matrix of factors inﬂuencing each component of the
equation. Nevertheless, prevalence proportions can help us
chart contours on the still-incomplete epidemiological map
of schizophrenia.
Several scholarly narrative reviews of the prevalence of
schizophrenia have been published in recent decades [4–8].
The sheer volume of data available on the prevalence of
schizophrenia now requires a more systematic and orderly
approach. As with many ﬁelds of medical knowledge, there is
a growing appreciation that reviews should be based on data
that are as complete and as free of bias as possible [9].
Systematic reviews have prespeciﬁed methods for locating
studies and for extracting and synthesizing the data. Not all
systematic reviews are accompanied by meta-analysis (i.e.,
pooling the data to provide one summary value) [10]. Even
without pooling of data, the orderly sorting of data using
meta-analytic techniques can provide useful insights into the
structure of the relevant literature [11].
One systematic review of the prevalence of schizophrenia
has been published to date [12]. This review (based solely on
census and/or community survey data) identiﬁed 18 studies
that provided estimates of either period and/or lifetime
prevalence of schizophrenia. Goldner and colleagues re-
ported pooled estimates for 1-y and lifetime prevalence of 3.4
and 5.5 per 1,000 persons, respectively. The authors com-
mented on the heterogeneity of the data and suggested that
this reﬂected ‘‘real variation’’ in the distribution of schizo-
phrenia around the world.
Recently, we published a systematic review of the incidence
of schizophrenia [1]. In brief, we found that the incidence of
schizophrenia varied widely between sites (persons, median=
15.2 per 100,000; 10%–90% quantiles = 7.7–43.0). In
addition, the study identiﬁed that (a) males were more likely
to develop schizophrenia than females (median male:female
risk ratio = 1.4); (b) migrants were more likely to develop
schizophrenia than native-born individuals (median risk ratio
= 4.6); and (c) individuals in urban sites had a higher risk of
developing schizophrenia than those in mixed urban/rural
sites. Regardless of the factors that underpin these incidence
gradients, would these same gradients also be found in the
prevalence of schizophrenia? If so, then it might suggest, for
example, that factors inﬂuencing the course of the illness
were more evenly distributed across these groups than factors
inﬂuencing the incidence of the disorder. If the prevalence
gradients are not congruent with the incidence gradients,
then we are faced with the challenging task of unraveling the
factors that could inﬂuence the differential course of
schizophrenia between risk groups.
In this paper we continue our cartography of the
epidemiological landscape of schizophrenia by presenting a
systematic review of the prevalence of this disorder.
Ways to Measure the Prevalence of Schizophrenia
Prevalence measures the proportion of individuals who
manifest a disorder at a speciﬁed time, or during a speciﬁed
period. Generally prevalence estimates are calculated as a
proportion, by dividing the total number of individuals who
manifest a disorder (the numerator) by the total population
at risk, including those with the disorder (the denominator).
Prevalence proportions vary according to temporal criteria
(e.g., point, period, or lifetime), but are not reported as an
index of events over time (i.e., they are not like incidence
rates that report the number of new cases per background
population per year). Prevalence proportions are often
loosely referred to as ‘‘rates’’; however, in this review we will
refer to them as ‘‘prevalence estimates’’ or ‘‘estimates.’’
Tables S1 and S2 deﬁne the types of prevalence estimates
used in this study, and provide descriptions of the variables
that we have used to describe the studies.
Point prevalence is the proportion of individuals who
manifest a disorder at a given point in time (e.g., 1 d or 1 wk),
while period prevalence measures the proportion of individ-
uals who manifest a disorder during a speciﬁed period of time
(e.g., 1 y). Given that the course of schizophrenia extends over
months to decades, estimates of point prevalence based on 1
d are comparable to those based on 1 mo [5]. Thus, in this
review we have combined all estimates based on temporal
criteria of 1 mo or less in ‘‘point prevalence,’’ while studies
that reported prevalence estimates between 1 mo and 12 mo
are included under the heading ‘‘period prevalence.’’
‘‘Lifetime prevalence’’ is the proportion of individuals in
the population who have ever manifested a disorder, who are
alive on a given day. It is important to emphasize that lifetime
prevalence needs to be clearly distinguished from ‘‘lifetime
morbid risk’’ (LMR; also described elsewhere as morbid risk
or expectancy). LMR differs from lifetime prevalence in that
it attempts to include the entire lifetime of a birth cohort
both past and future, and includes those deceased at the time
of the survey [13]. LMR is the probability of a person
developing the disorder during a speciﬁed period of their life
or up to a speciﬁed age. There are various ways to calculate
LMR [14,15]. The reviews of Odegaard [15], and Larsson and
Sjogren [16] noted that, for low-incidence disorders such as
schizophrenia, summation of age-speciﬁc incidence rates
gives almost the same result as other more complicated
methods of calculation [17]. The World Health Organization
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method’’ for the approximation of LMR. If one were to apply
Linnean principles in order to design a taxonomy of
frequency measures of disease, prevalence measures such as
point, period, and lifetime would be closely related species
within the same genus. However, there is a case to allocate
LMR to the Genus ‘‘Incidence’’ rather than the Genus
‘‘Prevalence.’’ Conceptually (but not mathematically), LMR
is closely related to cumulative incidence proportions derived
from birth cohort studies [19].
Traditional prevalence studies (henceforth referred to as
‘‘core’’ studies) generate an estimate based on the population
residing within a deﬁned catchment area. However, it should
be noted that the boundaries chosen for epidemiological
studies (e.g., health districts, cities, states, or nations) may not
be optimal for the detection of variations of the disorder
within or between various populations. Lumping populations
into large but convenient administrative areas can obscure
informative, ﬁne-grained gradients. With respect to preva-
lence estimates, factors such as the age structure of the
population, mortality rates, and migration patterns can
inﬂuence the estimates, and these may vary within and
between sites.
Apart from catchment-area-based studies of the general
population, there are many studies that report prevalence
estimates for subgroups of the population. These may include
groups deﬁned by narrow age strata (e.g., the elderly or
children), migrant status, ethnic or religious status, or twin
status, to name but a few. A recent paper has systematically
reviewed the prevalence of schizophrenia in prison settings
[20]; however, this will not be included in this review. Migrant
studies will be collated separately for analysis, while the
remaining subgroup prevalence estimates will be included in
‘‘other special groups.’’
Some studies report inpatient census data over a period of
time (e.g., 1 y) and use the count of unique individuals with
schizophrenia to generate a proportion based on general
population ﬁgures. While these studies may be useful for
administrative purposes, it is important not to mistake these
estimates as ‘‘true’’ prevalence proportions. Very few patients
require prolonged and continuous inpatient care; therefore,
prevalence proportions based on inpatient data alone grossly
underestimate true prevalence proportions. This review will
collate these studies separately (henceforth referred to as
‘‘inpatient-census-derived’’ data); however, they will not be
included in any of the main analyses.
Key Research Questions about the Prevalence of Schizo-
phrenia
First there is a need to examine the degree of variation in
the prevalence estimates of schizophrenia between sites. The
companion review on the incidence of schizophrenia [1]
found that within the central 80% of incidence rates, the
difference ranged from 7.7 to 43 per 100,000 (over a 5-fold
difference). While there has been debate within the schizo-
phrenia research community about whether this range of
rates is ‘‘narrow’’ or ‘‘prominent’’ (see review [21]), variations
in prevalence estimates have not been a focus of controversy.
The World Health Organization ten-country study com-
mented that the prognosis of schizophrenia [18] was better in
developing than in developed nations, a ﬁnding that has been
‘‘clear and consistent’’ in general [22]. The present review will
describe the distribution of the different types of prevalence
rates, and speciﬁcally examine whether the ‘‘developed versus
developing’’ status of the sites inﬂuences the distribution of
estimates.
Are the gradients that were identiﬁed in the incidence of
schizophrenia also reﬂected in the prevalence of the
disorder? For example, based on the previous ﬁnding that
males have a signiﬁcantly higher incidence of schizophrenia
[1,23], it would be predicted that this sex difference might
also be reﬂected in prevalence estimates. In addition, a recent
study from China [24,25] highlighted an apparently unusual
higher prevalence of schizophrenia in females in this country.
In light of this issue, the male:female prevalence ratio will also
be compared when the sites are sorted by a measure of
‘‘developed versus developing’’ status. Similarly, the inci-
dence review identiﬁed signiﬁcantly higher rates for (a) urban
place of residence when compared to mixed urban/rural sites,
and (b) migrant groups when compared to native-born
individuals. These gradients will also be explored regarding
the prevalence of schizophrenia.
Finally, systematic reviews can explore possible sources of
heterogeneity in data by sorting the data according to
methodological features. We will compare the distributions
of estimates based on the quality of the study (as assessed by
design features and thoroughness of reporting).
Methods
Identification of Studies
This systematic review conforms to the guidelines outlined
by the Meta-Analysis of Observational Studies in Epidemiol-
ogy (MOOSE) recommendations [26]. The search method-
ology for this review was identical to that of our previous
review paper on incidence of schizophrenia [1]. As a ﬁrst step,
a broad (free text) search string ([schizo* OR psych*] AND
[incidence OR prevalence]) was used in MEDLINE, PsychIN-
FO, EMBASE, and LILACS. Potentially relevant papers (in all
languages) were accessed in order to review the full text. The
references cited by each potentially relevant paper, review,
and book chapter were scrutinized in order to locate
additional potential papers. Posters were presented at two
international schizophrenia conferences [27,28] in order to
encourage researchers to contribute studies, especially
studies from the ‘‘grey literature’’ (e.g., conference reports,
theses, government reports, and unpublished studies). Sub-
sequently, letters or E-mails were sent to the senior authors of
papers that met the inclusion criteria. These authors were
provided with an interim list of included papers and asked to
nominate missing studies.
Included Studies
We included studies that reported primary data on the
prevalence of schizophrenia ﬁrst published between January
1965 and December 2002. Where multiple publications
presented identical data, the most ‘‘informative version’’ of
the study was included. Studies published in a language other
than English were translated, and relevant papers were
included.
Excluded Studies
Studies that reported prevalence data on prison or forensic
populations were excluded (see recent systematic review of
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logical studies that reported prevalence estimates in family
members of affected (index) probands. Some studies report
the LMR within large, multiplex families. These were not
included; however, if the prevalence estimates were based on
the entire population within a catchment area (e.g., an
isolated population living in a village), then they were
included.
Potential studies that had not been located at the time of
submission were allocated to the ‘‘awaiting assessment’’
category. Studies based on inpatient-census-derived propor-
tions are presented in the t a b l e sa n ds u m m a r i z e df o r
comparative purposes, but were excluded from the main
analyses.
Data Extraction
Once a study was included, data were extracted and
entered into a three-level normalized database (i.e., only the
unique prevalence estimate identiﬁer was allowed to occur in
more than one level) that included study-level variables (e.g.,
authors, year of publication, and site), middle-level variables
(e.g., urban/rural status, age group, recruitment duration, case
ﬁnding method, and diagnostic criteria), and rate-level
variables (e.g., sex-speciﬁc rates for persons, males, and
females). Two or more of the authors checked all data used
in the analysis. When disagreements arose, these were
resolved by consensus. If required, we contacted the original
authors for clariﬁcation of issues. The full electronic dataset
is available as Dataset 1.
Consistent with our previous systematic review of the
incidence of schizophrenia [1], studies were given ‘‘quality
points’’ based on operationalized features related to (a)
optimal research design (e.g., higher scores for greater
coverage, face-to-face interview versus chart diagnosis, and
reliability of instruments), and (b) quality of reporting (e.g.,
provision of numerator and denominator, and description of
diagnostic criteria). Details of the quality scores used in this
review are provided in Table S3.
Sorting Prevalence Estimates by the Application of
Sequential Filters
In systematic reviews, it is important that individuals are
not ‘‘double counted’’ by the same or different studies. Thus,
a key feature of this study is the application of sequential
ﬁlters in order to identify discrete prevalence estimates. We
applied a similar sorting algorithm as in our previous review
of incidence of schizophrenia [1]. Brieﬂy, the ﬁrst ﬁlter
parsed prevalence estimates from the included studies into
three groups: core, migrant, and other special groups. Next,
as the second ﬁlter, the estimates were sorted into six main
types: point (1 mo or less), period (between 1 and 12 mo),
lifetime, LMR, not otherwise speciﬁed (NOS), and inpatient-
census-derived data.
A third, study-level ﬁlter was applied in order to isolate
discrete data from multiple studies that overlapped in both
time and place. This third ﬁlter was used to select one
representative prevalence estimate for inclusion in the
cumulative distribution using the ‘‘most informative’’ rule.
For example, if one study presented multiple overlapping
estimates, the estimate based on the largest sample was
preferred (e.g., the widest age range was preferred over
narrower age strata). Furthermore, ﬁlter rules were deﬁned in
order to select discrete estimates such that they allowed the
greatest number of estimates to be included.
Presentation and Analyses of the Data
Key details of the included studies are presented in tables
sorted by country, year of publication and ﬁrst author (Tables
S4, S5, and S6). The distributions of prevalence estimates are
presented in cumulative plots, with every estimate contribu-
ting to the distribution. The distribution of the data is shown
in rank order for prevalence estimate (lowest to highest
ranks) with the cumulative percent of estimates shown on the
vertical axis. The plots show horizontal reference lines
indicating the 50% (median), and 25% and 75% quantiles
(between which lies the interquartile range). In order to aid
visual interpretation, some plots have been truncated,
excluding very high estimates. Key features of these distribu-
tions are presented in tables (e.g., median, mean, harmonic
mean, standard deviation, and quantiles at 10%, 25%, 50%,
75%, and 90%). These summary characteristics are based on
the entire distributions. Results are presented as prevalence
estimates per 1,000. In plots of prevalence ratios (e.g.,
male:female ratio), a vertical reference at the line of unity is
shown.
We wish to draw attention to several features of the graphs
used in this review. First, the central, near-linear segment of
the cumulative distributions may extend beyond the inter-
quartile range (e.g., from the 10%–90% quantiles), thus shape
features (where the tails start or the range of the linear
central segment) can be more informative than traditional
interquartile ranges. Second, steeper segments of the
cumulative plots are underpinned by estimates that have a
narrow distribution, while ﬂatter (i.e., more horizontal)
segments of the distribution are underpinned by data that
are relatively more dispersed. Finally, some distributions are
derived from more data than others. Regardless of slope (i.e.,
steep or ﬂat), if many estimates underpin segments of the
distributions, then inferences based on these segments are
probably more reliable than those based on segments
underpinned by less data.
Meta-analyses often display data points with conﬁdence
intervals, and formal tests of heterogeneity are usually
applied before combining data. For several reasons, the data
in this review do not lend themselves to this type of analysis.
Among the discrete core studies (see below), no study
provided conﬁdence limits to accompany the prevalence
estimate. One study, which was allocated to ‘‘other special
groups,’’ did provide conﬁdence limits [29]. Where studies
provided the corresponding numerator and denominator for
a prevalence estimate, we were able to derive standard errors.
However, we were able to impute standard errors for only
26% of the prevalence estimates, which were drawn from less
than half (45%) of the discrete core studies. Faced with such a
restricted pool of standard errors, the ability to assess the
heterogeneity of the estimates in a manner generalizable
across all core studies is compromised. In addition, the issues
that underlie the decision to combine data from randomized
controlled trials or risk factor epidemiological studies are of
less relevance to prevalence estimates, where estimates based
on very large populations should not necessarily carry more
weight than estimates based on small populations. Based on
ﬁrst principles, there is no reason to assume that prevalence
estimates for a disease remain static across time or place.
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estimate loses important information. In this review we wish
to draw attention to several characteristics of the distribution
of estimates (e.g., central tendency, shape and width of the
distribution, and density of data), rather than provide one
pooled estimate.
In keeping with our systematic review of the incidence of
schizophrenia [1], we supplement the graphical presentation
of the prevalence estimates with statistical analyses. These
analyses take into account (a) the need to control for within-
study variation (estimates drawn from the same study tend to
be more alike than estimates drawn from different studies),
and (b) the use of a log transformation of the data in order to
analyze distributions that are often positively skewed. Note
that the median value is more informative than the
arithmetic mean to assess central tendency in a skewed
distribution, as is the harmonic mean (which is calculated as
the exponential of the arithmetic mean of the log-trans-
formed data, also known as the geometric mean). The
analyses were carried out in SAS 9.1 using proc univariate
(for medians and other quantiles of the raw data) and proc
mixed for comparisons of harmonic means (because one
study may provide more than one estimate, it is important to
control for within-study variation).
Faced with a large quantity of data, systematic reviewers
need to keep a tight rein on the number of comparisons
undertaken on the data [30]. While it is tempting to reanalyze
data in the light of ﬁndings that emerge from the data, such
reanalyses should be kept to a minimum. The analysis of
prevalence estimates is particularly challenging because of
the many different prevalence types (e.g., point, period,
lifetime, and LMR). Thus, in order to minimize the number of
statistical comparisons in the current review, we restricted
the analyses to a limited set of planned sensitivity analyses,
Figure 1. Flow Diagram (Selection Strategy) of Included Studies
Double asterisk indicates exclusion categories (number studies excluded in parentheses). Double asterisk indicates numbers that are not
mutually exclusive. A few studies provided rates for more than one group (11 studies provided data for both core and migrant [n=3] or both
core and other special groups [n=8]; details in Results). LOTE, language other than English.
DOI: 10.1371/journal.pmed.0020141.g001
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analyses, applied multiple comparison corrections to the
nominal signiﬁcance levels by a Bonferroni correction.
Furthermore, these analyses were based on hybrid distribu-
tions, which merged four different prevalence estimate types
(point, period, lifetime, and NOS; henceforth referred to as
‘‘combined prevalence estimates’’). Apart from the speciﬁc
analyses related to sex differences, we undertook these
analyses on distributions for persons only (i.e., males and
females combined).
Hypotheses
Based on ﬁrst principles, we predicted that the estimates
for known prevalence types that include different temporal
criteria would be signiﬁcantly different. More speciﬁcally, we
predicted the following: (a) prevalence estimates for persons
would differ between lifetime, period and point (point being
the lowest), and (b) LMR estimates would be higher than
lifetime estimates.
There is now strong evidence that males have an increased
risk of developing schizophrenia [1,23]. We compared the
distribution for males versus females on the combined
prevalence estimates, predicting that males would have
distributions derived from higher estimates (i.e., distributions
for males would be right-shifted compared to distributions
for females).
In order to explore the inﬂuence of urbanicity of site on
the prevalence of schizophrenia, we divided the combined
prevalence estimates for persons into three categories (urban,
rural, and mixed urban/rural). Allocation was based on the
study descriptions of the area or, in the absence of these
descriptors, the review authors’ best estimate of this variable.
There are several reasons to predict that the prevalence of
schizophrenia would be higher in urban regions than in rural
regions. First, the incidence of schizophrenia is higher in
urban sites than mixed urban/rural sites [1]. Second, the
‘‘social drift’’ hypothesis suggests that the individuals with
schizophrenia are more likely to move into urban regions in
response to various factors related to poverty, the availability
of services, and easier access to cheap accommodation [31].
Finally, some commentators suggest that less industrialized
settings (e.g., rural regions and/or developing countries) may
facilitate recovery via social connectedness and easier access
to work [32]. Thus, we predicted that the prevalence of
schizophrenia would be higher in urban sites than in rural or
mixed urban/rural.
Migrants have a signiﬁcantly increased risk of developing
schizophrenia [1,33]. Assuming that the course of the illness
does not vary according to migrant status, based on combined
prevalence estimates for persons, we predicted that the
prevalence of schizophrenia would be higher in migrants
than in native-born individuals.
While there is a lack of evidence addressing whether the
incidence of schizophrenia varies with the economic status of
nations, there is solid evidence showing that people with
schizophrenia from developing countries tend to have better
outcomes than individuals in developed nations [18,22].
Mindful that there is a lack of consensus on how best to
deﬁne the multidimensional concept of economic develop-
ment, we have sorted prevalence estimates according to the
per capita gross national product of the study site (2004 data)
[34], and used standard World Bank deﬁnitions [35]: (a) least
Table 1. References by Type of Study
Type of Study References
Core studies (n=132) 18,36–38,40–42,44–51,53,54,56,59,60,62–64,72–79,81–91,93–98,100,102–104,107,
109–114,116,117,119,120,122–127,130–132,135–138,141–144,146,148,153–158,
160,162,163,165,167–171,174,176,177,179,181,183,184,186–188,190,193,195–198,
201–206,208–212,214–217,219–221,224
Migrant studies (n=15) (Note: three overlap with core studies) 39,43,55,65–68,92,129,133,173,175,180,200,207
Other special groups (n=41) 29,52,57,58,61,69,70,71,80,99,101,105,106,108,115,118,121,128,134,139,140,145,
147,149–151,159 114,161,164,166,172,178,182,185,189,191,192,194,199,213,218
DOI: 10.1371/journal.pmed.0020141.t001
Table 2. References by Type of Prevalence Estimate
Type of Prevalence References
Point prevalence (n=21) 36,40,54,62,64,93,95,98,104,116,126,132,135,148,153,160,181,187,195,202,220
Period prevalence (n=34) 37,40,44,45,51,60,72,76,78,85,94,100,102,103,110,112,114,122,123,130,148,153,160,
167,179,188,201,204–206,214–216,220
Lifetime prevalence (n=24) 37,45,49,50,60,63,64,78,79,83,100,112,116,123–125,153,183,187,203,209,211,220,222
NOS (n=32) 38,41,42,53,73–75,81,86,87,119,127,129,134,141,143,144,155,156,158,168,171,174,
176,177,193,197,212,213,217,219,221
LMR (n=9) 18,46,48,56,96,142,177,215,216
Inpatient-census-derived (n=44) 43,47,55,57,59,65–67,77,82,84,88–92,97,107,109,111,117,120,131,136–138,140,146,
152,154,157,162,163,165,182,184,186,189,190,196,198,208,210,223
DOI: 10.1371/journal.pmed.0020141.t002
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Country References
Argentina (n=1) 74
Australia (n=7) 55,105,106,115,182,194,207
Botswana (n=1) 44
Bulgaria (n=1) 187
Canada (n=14) 29,42,46–50,59,139,140,166,171,191,211
China (n=7) 63,64,160,177,212–214
Croatia (n=1) 83
Denmark (n=10) 18,51,52,82,107,137,138,148,149,189
Dominican Republic (n=1) 110
Ethiopia (n=3) 37,87,112
Finland (n=4) 61,99,126,127
France (n=2) 54,169
Germany (n=9) 69,70,75,76,92,97,158,161,209
Ghana (n=1) 181
Greece (n=1) 132
Iceland (n=2) 96,183
India (n=19) 18,62,78,79,81,135,141,144,145,155,156,168,172,174–176,184,188,193
Indonesia (n=1) 170
Iran (n=1) 41
Ireland (n=7) 18,111,152,196,215,216,221
Israel (n=2) 128,200
Italy (n=3) 162,186,220
Japan (n=6) 18,86,101,143,178,185
Lebanon (n=1) 109
Micronesia (n=3) 73,142,197
New Zealand (n=2) 153,203
Norway (n=4) 36,85,91,93
Papua New Guinea (n=1) 190
Portugal (n=1) 77
Puerto Rico (n=2) 60,180
Reunion Island (n=2) 90,102
Romania (n=1) 147
Russia (n=7) 18,56,119,154,179,217,219
South Africa (n=1) 167
South Korea (n=2) 124,125
Spain (n=2) 136,192
Sri Lanka (n=2) 103,206
Sweden (n=7) 94,117,130,150,151,204,205
Taiwan (n=3) 100,129,164
Tanzania (n=1) 53
The Netherlands (n=3) 45,98,173
Trinidad and Tobago (n=1) 146
United Kingdom (n=21) 18,39,40,43,65–68,71,80,84,88,95,104,114,133,134,157,165,208,210
United States (n=22) 18,38,57,58,89,108,113,116,118,120,121,123,159,163,180,195,198,199,201,202,208,
218
Uzbekistan (n=1) 131
Yugoslavia (n=2) 72,122
DOI: 10.1371/journal.pmed.0020141.t003
Table 4. References by Urbanicity of Sites
Urbanicity of Sites (Discrete-Core Studies) References
Urban 38,49,50,62–64,72,74,94,95,100,104,114,125,132,153,155,156,176,181,187,188,193,
195,201,205,206,209,211,217,219
Rural 36,41,42,44,54,64,81,100,103,125,134,135,141,144,148,158,167,168,177,205,213,215,
216,221
Mixed urban/rural 37,40,45,51,53,60,64,73,75,76,78,79,83,85–87,93,98,99,102,113,119,121,122,124,126,
127,129,130,143,166,171,173,174,179,180,183,197,202–205,212,214,220
DOI: 10.1371/journal.pmed.0020141.t004
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The Prevalence of Schizophreniadeveloped countries, = mean income of less than US$2,995;
(b) emerging economy countries, = mean income between
US$2,995 and $9,266; and (c) developed countries, = mean
income of greater than US$9,266. Thus, based on combined
prevalence estimates for persons, we predicted that the
prevalence of schizophrenia would be signiﬁcantly different
across the three economic categories, and that the prevalence
of schizophrenia would be signiﬁcantly lower in least
developed countries than in developed countries. Further-
more, a recent commentary drew attention to the apparent
female excess in the prevalence of schizophrenia in develop-
ing nations, in contrast to the male excess thought to
characterize the developed world [25]. Thus, based on
combined prevalence estimates, we compared the male:fe-
Figure 2. Cumulative Plots of the Point Prevalence Estimates per 1,000
by Sex
DOI: 10.1371/journal.pmed.0020141.g002
Figure 3. Cumulative Plots of the Period Prevalence Estimates per 1,000
by Sex
DOI: 10.1371/journal.pmed.0020141.g003
Figure 4. Cumulative Plots of the Lifetime Prevalence Estimates per
1,000 by Sex
DOI: 10.1371/journal.pmed.0020141.g004
Figure 5. Cumulative Plots of the LMR Estimates per 1,000 by Sex
DOI: 10.1371/journal.pmed.0020141.g005
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The Prevalence of Schizophreniamale ratio when the prevalence estimates were classiﬁed by
the three economic categories. We predicted that the ratio
would be signiﬁcantly different between the three economic
levels, and speciﬁcally, that the male:female ratio in devel-
oped nations would be signiﬁcantly higher than that of least
developed countries.
Finally, methodological features can inﬂuence prevalence
estimates. For example, studies that use comprehensive case
ascertainment methods (e.g., ‘‘door-knock’’ surveys, inpatient
and outpatient records, general practitioner surveys, and/or
surveys based on other community sources), should identify
more cases than those that rely on fewer recruitment sources.
Based on the combined prevalence estimates for persons, we
divided the estimates into quality score terciles. We predicted
that the prevalence estimates would be signiﬁcantly different
when assessed by quality score. More speciﬁcally, we
predicted that prevalence estimates from studies with the
highest quality score tercile would be higher than those from
the lowest tercile.
Figure 6. Cumulative Plots of the NOS Prevalence Estimates per 1,000 by
Sex
DOI: 10.1371/journal.pmed.0020141.g006
Figure 7. Cumulative Plots of the Inpatient-Census-Derived Prevalence
Estimates per 1,000 by Sex
DOI: 10.1371/journal.pmed.0020141.g007
Table 5. Quantiles and Moments of Point, Period, Lifetime, and NOS Prevalence per 1,000 by Sex
Prevalence Number of Studies
(Estimates)
Quantile Mean Standard
Deviation
Harmonic
Mean 10% 25% Median 75% 90%
Point prevalence (19 studies)
Persons 17 (23) 1.90 2.90 4.56 6.40 10.00 5.98 5.85 4.53
Males 10 (11) 1.68 2.60 4.31 9.00 11.00 8.06 10.43 5.04
Females 11 (12) 0.26 1.49 2.99 8.55 12.50 5.81 6.65 3.53
Period Prevalence (32 studies)
Persons 30 (42) 1.32 2.00 3.30 6.00 8.24 5.66 8.11 3.46
Males 15 (16) 1.00 2.36 3.75 6.25 20.00 6.21 7.34 4.47
Females 15 (16) 2.00 2.80 3.55 6.84 11.00 5.38 3.93 4.40
Lifetime Prevalence (21 studies)
Persons 20 (29) 1.83 3.00 4.00 6.55 11.55 5.53 4.47 4.31
Males 13 (17) 1.29 2.59 3.70 5.00 12.80 4.93 4.54 3.74
Females 13 (17) 0.71 1.59 3.80 7.00 11.40 4.76 3.78 3.36
NOS (32 studies)
Persons 29 (42) 1.40 2.20 2.69 3.50 4.80 4.71 7.31 2.92
Males 12 (15) 1.20 1.60 3.33 4.00 13.00 5.19 7.44 3.16
Females 12 (15) 1.27 2.00 2.60 3.70 13.00 5.83 10.69 3.42
DOI: 10.1371/journal.pmed.0020141.t005
PLoS Medicine | www.plosmedicine.org May 2005 | Volume 2 | Issue 5 | e141 0421
The Prevalence of SchizophreniaResults
The ‘‘Epidemiology’’ of Prevalence Estimates
The results of the search strategy, including source of the
studies, subsequent culling, and ﬁnal distribution of the
papers, are shown in Figure 1. The electronic search
identiﬁed 1,112 papers (85% of the total papers included in
the study), while manual reference checking identiﬁed an
additional 142 references (11%). We received responses from
31 authors (see Acknowledgments for full list), who provided
an additional 53 references (4%). We identiﬁed 98 studies
that were published in languages other than English. After
translation 17 of these studies were included in this review.
The list of references arranged by various criteria can be
found in Tables 1–4. The systematic review identiﬁed 188
studies that provided prevalence estimates [18,29,36–223].
These studies provided 1,721 estimates and were drawn from
46 countries. There were 132 core studies, 15 migrant studies
(of which three overlap with discrete core), and 41 studies
that reported the prevalence of schizophrenia in other
special groups.
Key features of these core, migrant, and special groups are
provided in Tables S4–S6. We excluded 26 studies that were
completely overlapping by time and place, and 19 studies that
reported prevalence data on prison populations (see Figure
1). However, ten partially overlapping studies were included
that provided at least one discrete rate for this review
[37,40,45,60,64,100,148,153,187,220].
The prevalence estimates were based on an estimated total
of 154,140 potentially overlapping cases. The 132 core studies
provided from one to 13 prevalence estimates per study. Four
studies [59,120,169,224] reported prevalence only within
narrow age strata without providing an overall rate. These
studies were not included in the discrete core analyses.
Of the 132 core studies, we identiﬁed 21 studies for point
prevalence, 34 studies for period prevalence, and 24 studies
for lifetime prevalence. Thirty-two studies provided no
information on the type of prevalence they reported—these
were allocated to NOS prevalence. There were nine studies
that reported LMR. Finally there were 44 studies that
reported inpatient-census-derived data.
The Distribution of Prevalence Estimates
Figures 2–7 and Tables 5–7 show the distribution of the
different types of prevalence estimates, and quantiles and
moments for persons, males, and females.
The median point prevalence for persons (based on 23
estimates) was 4.6 per 1,000, and the 10% and 90% quantiles
ranged from 1.9 to 10.0 per 1,000 (a 5-fold difference). The
median period prevalence for persons (based on 42 estimates)
was 3.3 per 1,000, and the 10% and 90% quantiles ranged
from 1.3 to 8.2 per 1,000 (a 6.5-fold difference). The median
lifetime prevalence for persons (based on 29 estimates) was
4.0 per 1,000, and the 10% and 90% quantiles ranged from
1.8 to 11.6 per 1,000 (a 6.4-fold difference).
There were 32 prevalence estimates that could not be
classiﬁed to the above criteria (NOS). Based on the
distribution of these prevalence estimates, the median
prevalence was 2.7 per 1,000 for persons, and the 10% and
90% quantiles ranged from 1.4 to 4.8 per 1,000 (a 3.4-fold
difference).
The median LMR for persons (based on 27 estimates) was
7.2 per 1,000, and the 10% and 90% quantiles ranged from
3.1 to 27.1 per 1,000 (a 8.7-fold difference) (see Table 6).
The review identiﬁed 108 estimates based on inpatient-
census-derived data. Based on the distribution of these
estimates for persons, the median value was 2.4 per 1,000,
and the 10% and 90% quantiles ranged from 0.07 to 10.0 per
1,000 (a 154-fold difference) (see Table 7). Inpatient-census-
Table 6. Quantiles and Moments of Studies with LMR per 1,000 by Sex
Group Number of Studies
(Estimates)
Quantile Mean Standard
Deviation
Harmonic
Mean 10% 25% Median 75% 90%
Persons 6 (27) 3.10 4.70 7.20 17.20 27.10 11.88 10.80 8.59
Male 7 (38) 1.46 3.15 4.05 7.10 14.80 6.23 5.85 4.53
Female 7 (38) 0.86 3.00 4.56 6.10 12.40 5.61 4.86 4.43
Data from nine studies.
DOI: 10.1371/journal.pmed.0020141.t006
Table 7. Quantiles and Moments of Studies with Inpatient-Census-Derived Data per 1,000 by Sex
Group Number of Studies
(Estimates)
Quantile Mean Standard
Deviation
Harmonic
Mean 10% 25% Median 75% 90%
Persons 34 (108) 0.07 0.53 2.38 6.25 10.03 6.50 14.36 1.75
Male 16 (175) 0.22 0.63 0.96 1.58 2.97 1.41 1.70 0.99
Female 16 (175) 0.11 0.40 0.73 1.40 2.97 1.28 1.76 0.79
Data from 44 studies.
DOI: 10.1371/journal.pmed.0020141.t007
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The Prevalence of Schizophreniaderived prevalence is not included for any subsequent
analyses.
When point, period, and lifetime estimates were compared,
the distributions were not signiﬁcantly different (F2,75 = 2.48,
p=0.09) . Estimates based on LMR were signiﬁcantly higher
than estimates based on lifetime estimates (F1,25 = 4.53, p=
0.04).
Male Versus Female Prevalence
Table 8 shows the moments and quantiles for the combined
prevalence estimates for persons, males, and females, and for
a ratio derived from male:female estimates. Figure 8 shows
the distribution of these data for males and females—these
distributions were not signiﬁcantly different (F1,72 = 0.68, p
= 0.41). For the male:female estimate ratio (based on 57
ratios), the median value was 1.11, and the 10% and 90%
quantiles were 0.50 to 1.70 (approximately a 3.4-fold differ-
ence) (see Figure 9).
Urbanicity of Sites
We identiﬁed 31 discrete-core studies with 73 rates from
urban sites (see Table 4), 24 studies with 48 rates from rural
sites, and 45 studies with 137 mixed urban/rural rates. There
were four discrete-core studies providing rates for both
urban (n=12) and rural (n=10) categories. Figure 10 and
Table 9 show the distribution of overall prevalence based on
rural, urban, and mixed urbanicity status for persons. While
the mixed urban/rural estimates were higher than urban and
rural rates, this difference was not statistically signiﬁcant
(F2,235 = 1.63, p=0.20), nor were urban estimates
signiﬁcantly different from rural estimates (F1,120 = 0.95, p
= 0.33).
Migrant Status
We identiﬁed 15 migrant studies from eight countries:
Australia (n=2; [55,207]), Germany (n=1; [92]), India (n=1;
[175]), Israel (n=1; [200]), Taiwan (n=1; [129]), the
Netherlands (n=1; [173]); United Kingdom (n=7; [39,43,65–
68,133]); and United States (n=1; [180]).
Table S5 presents a detailed list of migrant studies with key
descriptive variables, prevalence rates, and within-study
migrant:native-born estimate ratios.
The number of different migrant groups in one study
ranged between one and 38. There were six studies that
derived data from inpatient-census-derived prevalence
[43,55,65–67,92] and thus could not used in this analysis. In
addition, four migrant studies did not present data for
native-born populations [92,133,173,200]. Therefore, our
analysis was limited to ﬁve papers only [39,129,175,180,207].
Based on 22 prevalence ratios, the median migrant:native-
born prevalence ratio was 1.84 and the 10% and 90%
quantiles were 0.86 to 6.41 (approximately a 7.5-fold differ-
ence) (see Table 10; Figure 11). When the migrant versus the
native-born prevalence estimates were compared, there was a
signiﬁcant difference (F1,2 = 5.57, p=0.04).
Economic Status of Sites
Based on the three economic categories, we identiﬁed 19
estimates from least developed countries, 22 estimates from
emerging economy countries, and 96 estimates from devel-
oped countries (see Table 11; Figure 12). When divided by this
criterion, the prevalence estimate distributions were signiﬁ-
cantly different (F2,85 = 3.57, p=0.03), with the difference
attributed to the lower prevalence estimate distribution for
the less developed economies (developed versus least devel-
oped, F1,74 = 6.55, p=0.04). Table 12 also shows the
male:female prevalence estimate ratio when subdivided by
economic status. The distributions of these ratios (see Figure
13), were not signiﬁcantly different (F2,42 = 0.44, p=0.44).
Table 8. Quantiles and Moments of Combined Prevalence Estimates per 1,000 by Sex, and Male:Female Prevalence Estimate Ratio
Group Number of Studies
(Estimates)
Quantile Mean Standard
Deviation
Harmonic
Mean 10% 25% Median 75% 90%
Persons 85 (136) 1.44 2.28 3.30 5.94 10.00 5.41 6.79 3.61
Male 44 (59) 1.20 2.00 3.70 5.41 13.00 5.92 7.29 3.97
Female 45 (60) 1.23 2.00 3.15 6.83 11.70 5.40 6.58 3.67
Male:female estimate ratio 42 (57) 0.50 0.75 1.11 1.44 1.69 1.23 0.99 1.06
Data from 93 studies.
DOI: 10.1371/journal.pmed.0020141.t008
Table 9. Quantiles and Moments of Combined Prevalence Estimates per 1,000 for Persons by Urbanicity
Urbanicity Number of Studies
(Estimates)
Quantile Mean Standard
Deviation
Harmonic
Mean 10% 25% Median 75% 90%
Urban 31 (73) 1.20 1.85 2.90 4.70 7.00 4.70 7.23 3.08
Rural 24 (48) 1.00 2.00 2.95 3.75 5.80 4.31 7.21 2.82
Mixed 44 (134) 1.60 2.68 4.00 8.00 13.00 6.42 6.40 4.52
Data from 93 studies.
DOI: 10.1371/journal.pmed.0020141.t009
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When the combined prevalence estimates for persons were
divided into quality score terciles, the prevalence estimate
distributions were signiﬁcantly different (F2,105 = 4.79,p=
0.01), with the highest quality studies reporting signiﬁcantly
higher prevalence estimates than the other two terciles
(highest versus lowest quality scores, p=0.02) (Table 13;
Figure 14).
Other Special Group Studies
Details of these studies can be found in Table S6. We
identiﬁed 41 studies that reported the prevalence of
schizophrenia in other special groups. These studies came
from 14 countries: Australia (n=4), Canada (n=4),
Denmark (n=3), Finland (n=1), Germany (n=3), India (n
= 2), Israel (n=1), Japan (n=3), Romania (n=1), Spain (n
= 1), Sweden (n=2), Taiwan (n=1), United Kingdom (n=
2), and United States (n=5).
Prevalence estimates were obtained from a range of
population subgroups including elderly individuals (n=10;
[52,70,71,101,108,121,149–151,159]), ethnic groups (n=8;
[58,134,139,140,166,199,213,218]), Aborigines (n=4;
[105,106,115,164]), religious groups (n=5;
[29,80,128,182,191]), homeless individuals (n=4;
[118,161,192,194]), children and adolescents (n=3;
[57,185,189]), students (n=2; [147,178]), twins (n=1; [61]),
industrial workers (n=1; [172]), different castes (n=1;
[145]), and an isolate pedigree (n=1; [99]).
The marked heterogeneity of these data does not make
them suitable for combining. However, we note that
prevalence estimates in some homeless populations were
very high—300 per 1,000 persons for Sydney homeless
individuals [194] and 131 per 1,000 persons for Los Angeles
homeless individuals [118]. Conversely, some religious groups
had very low prevalence estimates—0.36 per 1,000 persons for
Amish individuals [80] and 1.29 per 1,000 persons for
Hutterite individuals [29].
Discussion
There is a wealth of data available on the prevalence of
schizophrenia—a total of 1,721 estimates from 188 studies
were identiﬁed in this systematic review. These estimates
were drawn from 46 countries, and were based on an
estimated 154,140 potentially overlapping prevalent cases.
The median prevalence estimates for persons were 4.6 per
1,000 for point prevalence, 3.3 for period prevalence, 4.0 for
lifetime prevalence, and 7.2 for LMR. These estimates are
congruent with an earlier narrative review of 70 studies by
Torrey [8], who reported an overall prevalence estimate of 4.6
per 1,000. Key policy documents have correctly estimated the
point prevalence of schizophrenia at about four per 1,000
[2,225]; however, the Diagnostic and Statistical Manual of Mental
Disorders, fourth edition (DSM-IV) [3], reported that the
lifetime prevalence of schizophrenia is ‘‘usually estimated to
be between 0.5% and 1%.’’ This overestimate is often
repeated in textbooks [226]. As with the misunderstandings
about the incidence of schizophrenia [21], this is another
example where the research community needs to review their
belief systems in the face of data. It is reasonable to assume
that lifetime prevalence estimates for schizophrenia would be
higher than point estimates. Surprisingly, the data in this
review do not support this assumption. While outside the
scope of the current review, the ﬁndings raise interesting
research questions about factors that may inﬂuence preva-
lence (e.g., recovery, suicide, or other forms of early mortal-
ity). Indeed, it is curious that the identiﬁcation of the onset of
psychotic disorders has received so much recent attention
Figure 8. Cumulative Plots of Combined Prevalence Estimates per 1,000
by Sex
DOI: 10.1371/journal.pmed.0020141.g008
Figure 9. Cumulative Plots of the Male:Female Prevalence Estimate Ratio
of Schizophrenia
DOI: 10.1371/journal.pmed.0020141.g009
PLoS Medicine | www.plosmedicine.org May 2005 | Volume 2 | Issue 5 | e141 0424
The Prevalence of Schizophrenia[227,228], while we still struggle to understand the offset of
schizophrenia. Point and period prevalence estimates assume
that we can identify when someone has recovered from an
illness. Recovery from schizophrenia clearly occurs [229–231],
but it is unclear whether those who are free of positive
symptoms but who have mild residual disability should be
counted as ‘‘active’’ cases or not. The deﬁnitions of recovery
versus persistence are multidimensional, and future preva-
lence studies will beneﬁt if these deﬁnitions can be
operationalized.
The median LMR estimate was 7.2 per 1,000, which is
consistent with two other narrative reviews. Fremming [232],
who reviewed 18 studies conducted in central Europe
between 1926 and 1938, reported a mean LMR of 7.4 per
1,000, while Gottesman and Shields [233] reported a mean
LMR of 8.0 per 1,000 in their classic review. As predicted,
LMR estimates were signiﬁcantly higher than lifetime
estimates, which reﬂects the different heritage of these two
indices. It is reasonable to assume that the oft-quoted statistic
that ‘‘schizophrenia affects about one in a hundred’’ derives
from LMR data (see [234]). However, one in a hundred is an
overestimate—our systematic review agrees with two previous
reviews showing that the LMR for schizophrenia is between
seven and eight per 1,000. While the arithmetic mean value of
11.9 per 1,000 is more consistent with the ‘‘one in a hundred’’
dogma, the median is a more appropriate measure of central
tendency for this skewed distribution. If we wish to provide
the general public with a measure of the likelihood that
individuals will develop schizophrenia during their lifetime,
then a more accurate statement would be that ‘‘about seven
to eight individuals per 1,000 will be affected.’’
While there has been considerable debate about whether
or not the incidence of schizophrenia varies between sites
[21], there is a tacit understanding that the prevalence of
schizophrenia is variable. For example, in an earlier review
by Eaton [5], a 12-fold variation in point and a 10-fold
variation in lifetime prevalence were noted. A recent
systematic review by Goldner et al. [12] also observed a 13-
Figure 10. Cumulative Plots of Combined Prevalence Estimates per 1,000
for Persons by Urbanicity
DOI: 10.1371/journal.pmed.0020141.g010
Figure 11. Cumulative Plots of the Migrant:Native-Born Prevalence
Estimate Ratio for Persons
DOI: 10.1371/journal.pmed.0020141.g011
Table 10. Quantiles and Moments of Combined Prevalence Estimates per 1,000 for Persons by Migrant Status, and Migrant:Native-
Born Prevalence Estimate Ratio
Migrant Status Number of Studies
(Estimates)
Quantile Mean Standard
Deviation
Harmonic
Mean 10% 25% Median 75% 90%
Migrants 6 (13) 1.20 1.94 2.80 4.00 13.75 5.36 6.75 3.43
Native 4 (4) 1.40 1.40 1.40 2.70 4.00 2.05 1.30 1.82
Migrant:native-born ratio 5 (22) 0.86 1.36 1.84 3.19 6.41 4.69 8.46 2.28
Data from six studies.
DOI: 10.1371/journal.pmed.0020141.t010
PLoS Medicine | www.plosmedicine.org May 2005 | Volume 2 | Issue 5 | e141 0425
The Prevalence of Schizophreniafold variation in lifetime prevalence of schizophrenia. Based
on the central 80% of the estimates (10% to 90% quantiles),
the present review found that the different types of
prevalence estimates had from 3.4-fold (point) to 4.6-fold
(period) variation. The use of the 10% and 90% quantiles to
deﬁne the central segment of the distribution means that our
reporting of the variability of estimates is more conservative
than other commentators (i.e., we have ignored 20% of the
distribution in the tails). If we had included all data points,
the range of prevalence estimates would have been much
higher. Regardless of whether this variability is labeled
‘‘narrow’’ or ‘‘prominent,’’ the task for the researchers is to
determine how much of this variation is a function of
measurement error versus ‘‘true’’ underlying variation. With
respect to measurement error, it should be noted that this
study found that quality of the study does signiﬁcantly
inﬂuence prevalence estimates. Future studies could explore
the impact of quality on the variation in prevalence
estimates.
Sex and Schizophrenia
One of the unexpected ﬁndings of this review was that
there was no statistically signiﬁcant difference in prevalence
estimates between males and females. In our previous study of
incidence of schizophrenia we found a male:female risk ratio
of 1.40 [1]. Because narrative reviews conclude that the course
of the illness tends to be more severe in men than in women
[235], we assumed that this would be reﬂected in a higher
prevalence in males than females. The lack of coherence
between (a) the sex differences found in the incidence of
schizophrenia, (b) the presumed difference in course of
illness, and (c) the identiﬁed lack of difference in prevalence
warrants closer scrutiny.
Economic Status and Schizophrenia
In keeping with our hypothesis, the prevalence of schizo-
phrenia is lower in developing nations than in developed
nations. However, we urge caution in the interpretation of
these data. The use of a single economic variable is a crude
way to assess a complex and multidimensional concept.
Furthermore, the median prevalence estimates for emerging
economies are numerically higher than those for the richest
countries. While not statistically signiﬁcant, the results did
identify many prevalence studies from the developing world
where females outnumbered males. Recently, a study from
China examined whether this unexpected sex ratio was due to
differential suicide rates in males with schizophrenia [24];
however, this did not seem to explain the female excess. Our
ﬁndings lend weight to the commentary by Ran and Yu-Hai
Chen [25], drawing attention to the different features of
schizophrenia in the developing world. Overall, the ﬁndings
suggest that factors that inﬂuence the course of illness of
schizophrenia in men and women differ around the world.
Regardless of the mechanisms underlying this possibility, the
ﬁndings highlight the importance of using systematic
techniques to identify data; 17 studies included in this review
were only available in languages other than English. We
speculate that the results of past narrative reviews may have
been biased towards data from developed nations. From a
wider perspective, the ﬁndings reinforce the importance of
encouraging more research from poorer countries [236].
Urbanicity and the Prevalence of Schizophrenia
In the previous systematic review of the incidence of
schizophrenia, we found that urban sites had signiﬁcantly
higher incidence rates of schizophrenia than mixed urban/
rural sites (there were too few pure rural sites to make the
Table 11. Quantiles and Moments of Combined Prevalence Estimates per 1,000 for Persons by Economic Status of Country
Economic Status
of Country
Number of Studies
(Estimates)
Quantile Mean Standard
Deviation
Harmonic
Mean 10% 25% Median 75% 90%
Least developed countries 18 (19) 0.60 1.85 2.62 4.33 6.19 3.05 1.99 2.42
Emerging economy countries 13 (22) 1.44 2.26 4.69 6.71 8.24 5.69 4.96 4.26
Developed countries 54 (95) 1.54 2.48 3.30 6.00 12.00 5.82 7.67 3.76
Data from 85 studies.
DOI: 10.1371/journal.pmed.0020141.t011
Figure 12. Cumulative Plots of the Combined Prevalence Estimates per
1,000 for Persons by Economic Status of Country
DOI: 10.1371/journal.pmed.0020141.g012
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The Prevalence of Schizophreniadirect urban versus rural comparison) [1]. Contrary to our
expectations, the prevalence of schizophrenia did not differ
according to urbanicity. While Figure 10 suggests that mixed
urban/rural sites have higher prevalence estimates than pure
urban and rural sites, this study found, in fact, that there was
no signiﬁcant difference between urban, rural, and mixed
sites. Perhaps the inclusion of many sites from the developing
world in this review has confounded the expected urban/rural
gradient. This will be examined in more detail in future
analyses.
Migrant Status and the Prevalence of Schizophrenia
As predicted, prevalence estimates for migrant groups tend
to be higher than estimates for native-born populations. This
ﬁnding is consistent with past systematic reviews of the
incidence of schizophrenia [1,33]. Migrant studies are prone
to a range of methodological issues (e.g., differential pathways
to care, diagnostic inaccuracies due to language and cultural
practices, and uncertainty about the denominator required
for the calculation of proportions). While the prevalence
estimates included in this systematic review may share
common biases, the increased prevalence of schizophrenia
in migrant groups found in this study adds weight to the
argument that migrant status is an important risk factor for
schizophrenia.
Quality Scores and Other Special Groups
Reassuringly, studies that had higher overall quality scores
tended to identify more cases, and thus generate higher
prevalence estimates than lower quality studies. Future
studies will explore whether the ﬁndings based on the overall
studies persist in the subgroup of studies in the highest
quality tercile.
With respect to the studies included in the category ‘‘other
special groups,’’ the estimates are not readily comparable, but
it is interesting to note that these studies reported a wide
range of prevalence estimates (e.g., high in homeless
populations and low in certain religious groups). Future
publications will examine these groups in more detail.
Caveats
Based on our experience with previous systematic reviews,
we acknowledge that we may have missed studies and/or made
data entry errors. We encourage readers to inform us of
missing studies or errors in the data. Updated lists of relevant
studies and raw data will be available from the authors.
Furthermore, in the absence of clear guidelines on how to
synthesize descriptive studies [26,237], many of the rules we
used to ﬁlter studies and extract data were necessarily ad hoc.
In the future, researchers may wish to reanalyze the dataset
using different criteria, and perform sensitivity analyses
related to these choices.
Two of the prevalence types (LMR and inpatient-census-
derived data) had distributions for persons that were higher
than distributions for both males and females separately. This
pattern, which is difﬁcult to explain, was also noted in some
of the previously published incidence distributions [1]. The
impact of quality scores on this pattern will be assessed in
future studies.
The planned sensitivity analyses were conducted on
combined data, a strategy that reduced the number of
comparisons substantially (one combined analysis versus ﬁve
analyses on each of point, period, lifetime, LMR, and NOS
data). However, the combined prevalence estimate included
studies that contributed more than one prevalence type (e.g.,
one study could contribute both point and period prevalence
Figure 13. Cumulative Plots of the Male:Female Prevalence Estimate
Ratio of Schizophrenia by Economic Status of Country
DOI: 10.1371/journal.pmed.0020141.g013
Figure 14. Cumulative Plots of Combined Prevalence Estimates per 1,000
for Persons by Tercile of Quality Score
DOI: 10.1371/journal.pmed.0020141.g014
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prevalence type to the combined prevalence estimates. While
the analytic technique controlled for within-study variance,
the combined dataset is not based on discrete data (in
contrast to the prevalence-type-speciﬁc analyses).
It was disappointing that standard errors could be
allocated to so few prevalence estimates (26%). Despite this,
in the future we plan to undertake a traditional meta-analysis
based on this subset of estimates in order to compare the
pooled estimate values with those presented in the current
study.
Concerning the analyses for urbanicity, the estimates from
mixed urban/rural studies are likely to be very heterogeneous.
Indeed, we allocated studies to the mixed category if there
was any possibility that rural sectors were included. This bias
would have made any true difference between urban versus
mixed urban/rural more difﬁcult to detect. There are good
reasons to review the ﬁndings for both urbanicity and sex
ratio more closely when categorized by economic status. Such
analyses may help generate hypotheses for future analyses,
but researchers need to be extremely cautious when system-
atic reviews are subjected to excessive data analyses (i.e., ‘‘data
torturing’’ [238]). The contributing studies were not designed
to test many of the hypotheses examined in this review,
therefore researchers must be frugal in the use of planned
sensitivity analyses, and cautious in the interpretation of the
results. However, researchers are encouraged to freely
explore the full data to examine additional research ques-
tions.
Conclusions
While there is substantial variation between sites, generally
the prevalence of schizophrenia ranges from four to seven
per 1,000 persons, depending on the type of prevalence
estimate used. Countries from the developing world have a
lower prevalence of schizophrenia. Overall, the prevalence of
schizophrenia does not vary between the sexes; however, the
data suggest that sex ratio of prevalence estimates may vary
between sites more than previously believed. While the
incidence of schizophrenia is higher in urban than rural
settings, this is not reﬂected in the overall prevalence data.
The prevalence of schizophrenia is higher in migrants than
native-born individuals.
Regardless of the exact magnitude and precision of
prevalence estimates, the numbers speak to a deeper, human
dimension. Many people with schizophrenia have persisting
symptoms, despite the best mix of interventions we can offer.
This sobering reality has also emerged from research about
‘‘best buys’’ with respect to the cost of averting disability
[239]. For schizophrenia, with the current mix of interven-
tions we can only reduce 13% of the burden. If we improve
efﬁciencies within the current services, we can do somewhat
better (22%). In a utopian world, even if unlimited funding
were available, three-quarters of the burden of schizophrenia
would remain unavoidable [240]. This is a powerful argument
for investing in applied and basic research.
As with its companion study on the incidence of
schizophrenia [1], we hope that the current review will
populate the ‘‘epidemiological landscape’’ with data, and that
this enriched environment will select the ﬁttest (most
heuristic) hypotheses [21]. The epidemiological landscape of
schizophrenia is no longer terra incognita—many of its
contours have been mapped out. We can gain traction on this
landscape and use the identiﬁed gradients to generate
candidate risk factors for future research [241]. Equally, these
systematic reviews have brought into focus the gaps in our
knowledge—parts of the map ‘‘do not ﬁt.’’ Paradoxes such as
these can be powerful catalysts for advancing knowledge.
Table 12. Quantiles and Moments of Male:Female Prevalence Estimate Ratio by Economic Status of Country
Economic Status
of Country
Number of Studies
(Estimates)
Quantile Mean Standard
Deviation
Harmonic
Mean 10% 25% Median 75% 90%
Least developed countries 5 (6) 0.22 0.36 0.70 1.36 6.46 1.64 2.40 0.83
Emerging economy countries 9 (10) 0.53 0.62 0.86 1.32 1.64 0.99 0.44 0.91
Developed countries 28 (41) 0.68 0.88 1.14 1.47 1.67 1.23 0.77 1.14
Data from 42 studies.
DOI: 10.1371/journal.pmed.0020141.t012
Table 13. Quantiles and Moments of Combined Prevalence Estimates per 1,000 for Persons by Tercile of Quality Score
Tercile of
Quality Score
Number of Studies
(Estimates)
Quantile Mean Standard
Deviation
Harmonic
Mean 10% 25% Median 75% 90%
Low 28 (51) 1.26 2.10 2.88 4.66 7.50 4.02 3.83 2.90
Medium 27 (39) 1.50 2.01 2.90 5.40 11.00 5.23 7.38 3.34
High 32 (46) 1.90 3.00 5.18 5.18 15.00 7.12 8.44 4.91
Data from 85 studies.
DOI: 10.1371/journal.pmed.0020141.t013
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Patient Summary
Background. Schizophrenia is a very serious mental illness and a major
contributor to the global burden of disease. The topic of this study is the
question of how common schizophrenia is among different groups and
in different countries around the world. ‘‘Prevalence’’ means the number
of people who have the disease at a particular time. The study itself is a
so-called systematic review, which means the researchers used
prespecified methods for finding individual studies and for extracting
and summarizing the data from these individual studies in as objective a
way as possible.
Why Was This Study Done? Health care planning is based on
prevalence estimates, and as a result, many studies on schizophrenia
prevalence have been done by researchers around the world. The
authors decided to do a systematic review of these studies to come up
with a scientifically sound view of the big picture.
What Did the Researchers Do? They looked at a total of 1,721 estimates
of the prevalence of schizophrenia from 188 studies and covering 46
countries. They then calculated median prevalence estimates (that is, the
middle value of all estimates) over a variety of time periods (see below).
What Did They Find? The take-home message from their study is that
about seven to eight individuals out of 1,000 will be affected by
schizophrenia. To be more precise, the researchers found the following
median estimates for the prevalence of schizophrenia: 4.6 out of 1,000
people have the disease at a specific time point; 3.3 per 1,000 have the
disease within a surveillance period one to 12 months long; the lifetime
prevalence (the number of people in the population who have ever
manifested the disease) is 4.0 per 1,000; and the lifetime morbid risk (the
likelihood that a particular individual will develop schizophrenia in their
lifetime) is 7.2 per 1,000. While previous research has shown that men
have a higher risk of developing schizophrenia, the researchers found
that the prevalence of schizophrenia was the same in men and women
(suggesting that the course of the illness differs between the sexes). The
prevalence of schizophrenia was lower in poorer countries than in richer
countries.
What Does This Mean? Based on these estimates, our textbook
numbers on lifetime prevalence and overall risk for an individual to
develop schizophrenia are probably too high. Taken together with
estimates on the incidence of schizophrenia (that is, the annual number
of new cases), it is also clear that current treatments fail to cure most
patients with schizophrenia.
More Information Online. Additional information on schizophrenia can
be found at the following sources.
United States National Institutes of Mental Health (search for ‘‘schizo-
phrenia’’): http://www.nimh.nih.gov/
Schizophrenia.com, a not-for-profit Web site providing information and
education on schizophrenia: http://www.schizophrenia.com
For an explanation of systematic reviews: http://www.shef.ac.uk/scharr/
ir/units/systrev/definitions.htm; http://www.cochrane.org/index0.htm
For definitions of incidence and prevalence: http://www.
wrongdiagnosis.com/admin/preval.htm
For more information about the systematic reviews of the incidence and
prevalence of schizophrenia: http://www.qcmhr.uq.edu.au/epi/
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